Back to 
Grantham, Mayo, Van Otterloo & Co. LLC
Grantham, Mayo, Van Otterloo & Co. LLC
PTGX
Showing 0 of 4 quarters
Position history for Grantham, Mayo, Van Otterloo & Co. LLC's holdings in Protagonist Therapeutics, Inc.
No. Grantham, Mayo, Van Otterloo exited its PTGX position in Q2 2020. Its Q1 2020 13F listed 18,300 shares worth $129,000. Grantham, Mayo, Van Otterloo first reported PTGX in Q3 2019 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.